Accessibility Tools
GeoVax receives BARDA Project NextGen Award for COVID-19 Vaccine
BARDA provides $24 million under Project NextGen for clinical trial of novel COVID-19 vaccine candidate that may provide broader, longer protection
Project NextGen
